AIBP-mediated cholesterol efflux instructs hematopoietic stem and progenitor cell fate
Author(s) -
Qilin Gu,
Xiaojie Yang,
Jie Lv,
Jiaxiong Zhang,
Bo Xia,
JunDae Kim,
Ruoyu Wang,
Feng Xiong,
Shu Meng,
Thomas P. Clements,
Bhavna Tandon,
Daniel S. Wagner,
Miguel F. Diaz,
Pamela L. Wenzel,
Yury I. Miller,
David Traver,
John P. Cooke,
Wenbo Li,
Leonard I. Zon,
Kaifu Chen,
Yongping Bai,
Longhou Fang
Publication year - 2019
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aav1749
Subject(s) - notch signaling pathway , biology , haematopoiesis , microbiology and biotechnology , chromatin immunoprecipitation , transcription factor , progenitor cell , stem cell , chromatin , hematopoietic stem cell , signal transduction , genetics , gene , gene expression , promoter
Regulating HSC progenitors via cholesterol Atherosclerosis is characterized by the buildup of cholesterol-containing lipoproteins in the vascular wall. This increased cholesterol augments hematopoietic stem and progenitor cell (HSPC) counts, and the resultant increase in leukocytes is associated with increased cardiovascular disease. Guet al. describe a mechanism orchestrating HSPC specification from the hemogenic endothelium (HE) during embryogenesis (see the Perspective by Rajan and Berman). ApoA-I binding protein accelerated cholesterol efflux from the HE, activating the transcription factor Srebp2, which in turn transactivated Notch signaling. This mechanism also appears to be important for adult HSPC expansion in hypercholesterolemia.Science , this issue p.1085 ; see also p.1041
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom